A clinical evaluation of a CVC securement device
| ISRCTN | ISRCTN13939744 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN13939744 |
| Protocol serial number | 18974 |
| Sponsor | University Hospitals Birmingham NHS Foundation Trust |
| Funder | 3M Deutschland GmbH |
- Submission date
- 08/07/2015
- Registration date
- 09/07/2015
- Last edited
- 23/04/2019
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Signs and Symptoms
Plain English summary of protocol
Background and study aims
Central venous catheters (CVC) are inserted into many patients for the administration of treatment and haemodynamic monitoring (for measuring blood pressure and oxygen levels in the blood) . Sutures (stitches) are frequently used to secure CVC onto the skin, however application of sutures carries a risk of needle stick injury to the clinician, discomfort to the patient and trauma at the CVC insertion site. Moreover, the sutures securing CVC are often highly colonized with bacteria despite scrupulous CVC site care, and may serve as a source for an infection. CVC movement may introduce microorganisms from the skin surface along the CVC and contribute to an infection. Therefore alternative securement methods for short term CVC needs to be tested. Alternative CVC securement methods are available, such as adhesive devices/tapes/dressings; however these have been used for securing CVC that are placed through veins in the arm. Knowledge of securement device for CVC, which are inserted into neck, chest or groin, is limited. This study will test the safety of the device, whether what is being measured is appropriate and measurable and whether the device is acceptable to clinical users.
Who can participate?
Adults (18 or over) being treated, or about to be treated, in a critical care unit and needing a CVC.
What does the study involve?
Participants are randomly allocated into one of two groups. Those in group 1 have sutures securing their CVC. Those in group 2 have the CVC securement device applied to secure the CVC. The patients are observed for any CVC related complications and CVC placement is measured daily. Comfort of the patient and user acceptability is evaluated where appropriate.
What are the possible benefits and risks of participating?
Participants may not have any direct medical benefit from being in this study; however the information gained from this study will help improve the treatment of future patients who have a catheter inserted as part of their medical care. Catheter stabilization is recognised as an intervention to decrease the risk for phlebitis and catheter displacement, and may be advantageous in preventing catheter related bloodstream infections. Risks include skin irritation and damage to the skin, improper use of the catheter securement system or displacement of it, infection and air embolism.
Where is the study run from?
University Hospitals Birmingham NHS Foundation Trust (UK).
When is the study starting and how long is it expected to run for?
June 2014 to June 2017
Who is funding the study?
3M Deutschland GmbH
Who is the main contact?
Dr Tarja Karpanen
Contact information
Scientific
University Hospitals Birmingham NHS Foundation Trust
Queen Elizabeth Hospital
Mindelsohn Way
Edgbaston
B15 2GW
United Kingdom
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised; Interventional; Design type: Treatment |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | A clinical evaluation of two central venous catheter stabilization systems |
| Study objectives | The aim of this feasibility study is to assess the safety of a new securement device for central venous catheters (CVC), to see whether the proposed study parameters are appropriate and measurable, and the securement device is acceptable to clinical users. |
| Ethics approval(s) | NRES Committee North West – Greater Manchester South, 27/04/2015, ref: 15/NW/0185 |
| Health condition(s) or problem(s) studied | Topic: Critical care; Subtopic: Critical care; Disease: All Critical care |
| Intervention | CVC securement: a short-term central venous catheter is secured onto the skin using either sutures and a transparent dressing, or a sutureless securement system which consists of a molded plastic device with an adhesive backing and a transparent film dressing. |
| Intervention type | Device |
| Phase | |
| Drug / device / biological / vaccine name(s) | |
| Primary outcome measure(s) |
Total number of catheter dislodgements. Recorded daily (for the duration of CVC placement) using standard clinical observation methods. |
| Key secondary outcome measure(s) |
1. Number of complete catheter dislodgements (i.e. number of unplanned catheter removals) |
| Completion date | 14/06/2017 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Sex | All |
| Target sample size at registration | 168 |
| Total final enrolment | 186 |
| Key inclusion criteria | 1. ≥18 years of age 2. Admitted, or to be admitted, to a critical care unit 3. Require a single, short-term, non-cuffed, non-tunnelled CVC (up to and including 12F in size) as part of their clinical care 4. Willing and able to provide written informed consent (or if their condition do not allow this their legally authorized representative willing and able to give the consent on their behalf) |
| Key exclusion criteria | 1. Confused (patients who have a positive CAMICU score or if confusion expected after sedation stopped) 2. Excessively perspiring (skin becomes moist within 2 minutes of drying) 3. Non adherent skin burn, trauma or other condition affecting the skin integrity in close proximity to the potential insertion site, so that the device/ suture is applied to the skin without any of these conditions 4. Underlying uncorrected bleeding diathesis 5. Known allergy to adhesives or device components 6. To have more than one catheter inserted at the same location 7. Pregnant or breastfeeding women 8. Past participants in this study |
| Date of first enrolment | 08/09/2015 |
| Date of final enrolment | 31/01/2017 |
Locations
Countries of recruitment
- United Kingdom
- England
- France
- Spain
Study participating centres
B15 2GW
United Kingdom
75018
France
86021
France
25198
Spain
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not expected to be made available |
| IPD sharing plan | The datasets are not made publicly available as consent from patients were not sought for data to be used for other research/sent outside of EU |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 17/04/2019 | 23/04/2019 | Yes | No |
| Basic results | 06/09/2018 | 06/09/2018 | No | No | |
| HRA research summary | 28/06/2023 | No | No | ||
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
Additional files
- ISRCTN13939744_BasicResults_06Sep2018.pdf
- Uploaded 06/09/2018
Editorial Notes
23/04/2019: The following changes have been made:
1. Publication reference added.
2. The total final enrolment has been added from the results publication.
06/09/2018: The basic results of this trial have been uploaded as an additional file
04/12/2017: Contact email address changed from Tarja.larpanen@uhb.nhs.uk to tarjakarpanen@hotmail.com
30/11/2017: The overall trial dates have been updated from 22/06/2015-31/12/2015 to 18/06/2014-14/06/2017. The recruitment dates have been updated from 22/06/2015-31/12/2015 to 08/09/2015-31/01/2017.
